Answers are grounded in this paper and cite their sources.
Observational analysis demonstrated that Pseudomonas aeruginosa disrupts airway integrity, highlighting Lactobacillus casei's protective role in inflammation.
Polymicrobial-host crosstalk shapes airway barrier integrity and inflammation, yet standard in vitro systems rarely sustain interaction-dependent phenotypes. We engineered an aqueous two-phase system (ATPS) confined bronchial co-culture that stabilized day-scale assays while maintaining epithelial function. A 16HBE14o-/HUVEC cell insert model was challenged with Pseudomonas aeruginosa PA01, Streptococcus pneumoniae D39, and the commensals Rothia mucilaginosa and Lactobacillus casei in mono- and polymicrobial combinations. We evaluated epithelium permeability to FITC-dextran, cell junction integrity, bacterial-induced cytotoxicity, IL-6 and IL-8 release and bacterial viability. ATPS preserved a workable assay window and bacterial confinement over 24h. PA01 disrupted barrier integrity, and commensals mitigated this pathogenic effect, whereas PA01 co-cultured with S. pneumoniae exhibited synergistic damage effects on the lung epithelium. Junctional imaging corroborated functional readouts, and cytotoxicity remained low across conditions. Cytokine shifts were condition-specific but modest, demonstrating compatibility for soluble mediator profiling. We generated a human airway-microbiome model in which ATPS confinement enabled modelling of dynamic lung-microbiome interactions, reproducing known P. aeruginosa pathogenic effects and commensal protection of the epithelium.
No takes yet. Share an insight, caveat, or question.
Spencer et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: